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SOX10 Maintains Multipotency and Inhibits Neuronal
Differentiation of Neural Crest Stem Cells
tion (Ohtsuka et al., 1999; Nakamura et al., 2000).
However, such inhibition does not necessarily maintain
multipotency. For example, in the peripheral nervous
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system (PNS), Notch restricts neural crest stem cellsDivision of Biology 216-76
(NCSCs) to nonneuronal fates and promotes glial differ-California Institute of Technology
entiation (Morrison et al., 2000). Studies of CNS stemPasadena, California 91125
cells have yielded conflicting data on this point (Tanigaki
et al., 2001; Hitoshi et al., 2002). The HLH protein Id has
been shown to inhibit differentiation and proliferativeSummary
arrest (Benezra et al., 1990; Wang et al., 2001), but
whether it maintains multipotency has not been deter-The mechanisms that establish and maintain the multi-
mined.potency of stem cells are poorly understood. In neural
Although multipotency is a key property of stem cells,crest stem cells (NCSCs), the HMG-box factor SOX10
it has been difficult to study. That is because multipo-preserves not only glial, but surprisingly, also neuronal
tency is a latent property, which can be revealed onlypotential from extinction by lineage commitment sig-
by exposing stem cells to conditions that elicit overtnals. The latter function is reflected in the requirement
differentiation. While in vivo transplantation is the mostof SOX10 in vivo for induction of MASH1 and PHOX2B,
general method for assessing developmental potential,two neurogenic transcription factors. Simultaneously,
in the nervous system it does not readily lend itself toSOX10 inhibits or delays overt neuronal differentiation,
clonogenic assays (reviewed in Anderson, 2001). Conse-both in vitro and in vivo. However, this activity requires
quently, apparent changes in the multipotency of heter-a higher Sox10 gene dosage than does the mainte-
ogenous populations of transplanted precursors maynance of neurogenic potential. The opponent func-
reflect either changes in stem cell potential or in thetions of SOX10 to maintain neural lineage potentials,
proportion of lineage-restricted progenitors (McConnellwhile simultaneously serving to inhibit or delay neu-
and Kaznowski, 1991; Frantz and McConnell, 1996). Inronal differentiation, suggest that it functions in stem
vitro clonogenic culture systems can help to distinguishor progenitor cell maintenance, in addition to its estab-
between these alternatives. However, such an approachlished role in peripheral gliogenesis.
requires that instructive differentiation signals for the
stem cells be identified in order to assess their develop-
Introduction mental capacities. There are relatively few systems in
which this extent of characterization has been achieved
Stem cells are self-renewing progenitor cells with the (e.g., Shah et al., 1994, 1996; Johe et al., 1996; reviewed
capacity to generate multiple differentiated derivatives in Temple, 2001).
(reviewed in Morrison et al., 1997). In developing em- One such system is that established for neural crest
bryos, stem cells serve to construct tissues and organs stem cells (NCSCs). NCSCs behave in vitro as multipo-
de novo, while in adults they maintain ongoing cellular tent, self-renewing PNS neural progenitors (Stemple and
turnover and provide regenerative capacity in certain Anderson, 1992) that can differentiate to autonomic neu-
tissues. Different categories of stem cells have been rons, glia, and smooth muscle cells (reviewed in Ander-
described, with different self-renewal and develop- son, 1997). (NCSCs do not generate sensory neurons
mental capacities, in different tissues, and at different [Greenwood et al., 1999; White and Anderson, 1999;
stages of development (reviewed in Weissman et al., White et al., 2001; Lo et al., 2002] and therefore contrib-
2001). While much has been learned about the cellular ute to a subset of neural crest derivatives in vivo [Le
and molecular control of stem cell differentiation, espe- Douarin and Kalcheim, 1999]). The differentiation of
cially in the nervous system (reviewed in Gage, 2000; NCSCs in vitro can be promoted by specific instructive
Anderson, 2001; Temple, 2001; Tsai et al., 2002), rather extracellular signals. Glial growth factor II (GGFII), also
less is known about factors that maintain the stem cell known as Neuregulin-1 (NRG-1), promotes Schwann cell
state. (glial) differentiation, BMP2/4 promotes autonomic neu-
Maintenance of the stem cell state involves at least ronal and smooth muscle differentiation, while TGF
three distinct functions: (1) inhibition of overt differentia- promotes smooth muscle differentiation (Shah et al., 1994,
tion, (2) maintenance of proliferative capacity, and (3) 1996). The hierarchical influences and relative kinetics
maintenance of multipotency. Relatively few molecules of lineage restriction promoted by these factors have
have been identified for these functions. In the central also been characterized (Shah and Anderson, 1997).
Here we have employed these instructive signals to-nervous system (CNS), components of the Notch signal-
gether with retrovirus-mediated gene transfer to investi-ing pathway and its downstream transcriptional ef-
gate the role of a transcriptional regulator, SOX10, infectors, such as Hes genes, inhibit neuronal differentia-
the control of multipotency. Sox10 is a member of the
high-mobility (HMG) group gene family, which includes*Correspondence: mancusog@caltech.edu
the testis-determining factor Sry (Koopman et al., 1991)1Present address: Division of Molecular Life Sciences, Ewha Wom-
and Sox2, a marker of CNS stem cells (Kuhlbrodt et al.,ans University, Seoul, Korea.
2 These authors contributed equally to this work. 1998; Wegner, 1999; Bowles et al., 2000; Zappone et
Neuron
18
al., 2000). Sox10 is specifically expressed in neural crest (Paratore et al., 2001). As neuronal and smooth muscle
differentiation can be promoted by BMP2/4 and TGFcells, just as they migrate from the dorsal neural tube
(Shah et al., 1996), we asked whether these factors pro-(Southard-Smith et al., 1998). Loss-of-function muta-
moted downregulation of SOX10 expression in advancetions in the Sox10 (or Dom) locus cause dominant, cell-
of such overt differentiation. Application of BMP2 orautonomous defects in Schwann cell and melanocyte
TGF1 caused an extinction of SOX10 expression indifferentiation, while homozygous mutants exhibit em-
90% and 75% of NCSCs, respectively, within 24 hr (Fig-bryonic lethality with failure of migration and/or differen-
ures 1L–1Q), while it was maintained in GGFII/NRG-1,tiation of multiple neural crest derivatives, including glia
as expected (Figures 1R and 1S). Thus, downregulationand autonomic neurons (Herbarth et al., 1998; Southard-
of SOX10 expression is an early event in the rapid lineageSmith et al., 1998; Britsch et al., 2001; Potterf et al.,
restriction promoted by BMP2 and TGF1 (Shah and2001; Sonnenberg-Riethmacher et al., 2001). Studies of
Anderson, 1997).neural crest cells cultured from Sox10/ mouse em-
bryos have shown that the gene is required for glial
SOX10 Maintains Gliogenic Potential in NCSCsdifferentiation (Paratore et al., 2001). However, more ex-
The observation that SOX10 expression is maintainedtensive analysis of Sox10 loss-of-function phenotypes
in Schwann cell precursors, but rapidly downregulatedin such cultures is impeded by the extensive apoptosis
by factors that promote differentiation to nonglial fates,caused by the mutation. Therefore, whether SOX10
raised the question of whether it is required for the main-plays a broader role in maintaining multipotency could
tenance of glial potential. To address this question, wenot be determined.
first asked whether BMP2 promoted a loss of gliogenicGain-of-function experiments would complement the
differentiation potential in NCSCs, and if so, whetherunderstanding of SOX10 function gleaned from loss-
this could be prevented by constitutive expression ofof-function analysis. However, previous studies have
Sox10. To achieve such constitutive expression, we in-reported that overexpression of Sox10 yields no obvious
fected NCSCs with pseudotyped retroviruses (Kinsellaphenotype in cultured rodent neural crest cells or in
and Nolan, 1996) expressing either a SOX10-IRES-GFPchick embryos (Paratore et al., 2001). Here we report
cassette or GFP alone. Under the conditions used (seethat constitutive expression of SOX10 in NCSCs pre-
Experimental Procedures), most or all (90%) of theserves both glial and, surprisingly, neuronal differentia-
colonies were infected. After 24 hr to permit expressiontion potentials. The maintenance of neurogenic potential
of the virally encoded transgene, the cells were preincu-is opposed by an independent function of SOX10 to
bated with or without 1 nM BMP2 for a further 24 hrinhibit or delay overt neuronal differentiation. SOX10
(Figure 2, flow diagram). Following washout of BMP2,also prevents TGF-induced proliferative arrest. Together,
glial differentiation potential was assayed by culturingthese data suggest that SOX10 contributes to the main-
the cells for several additional days in GGFII/NRG-1 andtenance of stem cell properties in the neural crest.
staining for GFAP. In some experiments, the cells were
further cultured in a maturation medium (Stemple andResults
Anderson, 1992; Shah et al., 1994) (see Experimental
Procedures) and stained for O4, a surface marker of
SOX10 Is Expressed in Multipotent NCSCs
more mature Schwann cell precursors (Sommer and
and Downregulated in Nonglial Progeny
Schachner, 1981).
Using a monoclonal antibody to SOX10 (Lo et al., 2002; In control GFP retrovirus-infected NCSCs, BMP2 pre-
Zirlinger et al., 2002), we confirmed that the protein is incubation caused a complete loss of gliogenic poten-
expressed early in neural crest migration in rat embryos tial, as reflected in a lack of both GFAP (Figures 2B
(Figure 1A) and maintained in satellite glia and Schwann versus 2D; Figure 2Q, lavender bars) and O4 expression
cell precursors, while being downregulated in neuronal (Figures 2J versus 2L; Figure 2R, lavender bars). Rather,
derivatives (Figures 1B and 1C). In vitro, virtually all p75, most NCSCs differentiated to neurons (Figures 2C and
lin (lineage marker, e.g., neurofilament, GFAP, etc.) 2K) and smooth muscle cells (data not shown). The rapid
neural crest cells derived from rat E10.5 neural tube extinction of glial differentiation capacity was not due
explants expressed SOX10 when plated at clonal den- to a selective killing of glial progenitors by BMP2, since
sity (Figures 1D and 1E). Since most or all of these cells this factor causes little or no cell death in a 24 hr incuba-
can clonogenically generate neurons, glia, and smooth tion (Shah et al., 1996; Shah and Anderson, 1997) (data
muscle cells as well as self-renew (Stemple and Ander- not shown).
son, 1992), these data support the idea that SOX10 is Constitutive expression of SOX10 prevented the ex-
expressed by multipotent NCSCs. Similar conclusions tinction of gliogenic potential by BMP2 in 80% of in-
have been drawn indirectly in mouse (Paratore et al., fected clones, as evidenced by the recovery of GFAP
2001), although NCSCs have not been clonogenically expression (Figures 2D versus 2H; Figure 2Q, “BMP2,”
defined in that system. purple bar). Recovery of O4 expression in SOX10-infected
When NCSCs were allowed to differentiate to all three cells was also observed after sequential incubation in
lineages under standard culture conditions (Stemple GGFII/NRG-1 and maturation medium (Figure 2L versus
and Anderson, 1992), SOX10 expression was extin- 2P), although the extent was not as great as for GFAP
guished in smooth muscle cells (Figures 1F and 1G) and (Figure 2R, “BMP2,” magenta bar). These data indicate
neurons (Figures 1H and 1I) but maintained in Schwann that constitutive expression of SOX10 can prevent
cells (Figures 1J and 1K). These results are consistent BMP2 from extinguishing gliogenic potential in NCSCs.
with the pattern of SOX10 expression in vivo (see above), SOX10 also preserved gliogenic potential from extinc-
tion by TGF (see below).as well as with earlier studies in mouse neural crest cells
SOX10 Maintains Neural Crest Lineage Potentials
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Figure 1. Expression of SOX10 Protein by
Neural Crest Cells In Vivo and In Vitro
(A–C) Cross-sections through developing rat
spinal cord at E10.5 (A) and E13.5 (B and C)
showing expression of SOX10 in migrating
neural crest cells (A) and in satellite glia at the
perimeter of the DRG (B) as well as in Schwann
cell precursors in peripheral nerve (C).
(D–S) Expression of SOX10 (green nuclei in
all panels) by NCSCs and their derivatives
in vitro. (D), (F), (H), (J), (L), (N), (P), and (R)
represent phase-contrast images of the
epifluorescence images shown in (E), (G), (I),
(K), (M), (O), (Q), and (S), respectively. (D and
E) Coexpression of SOX10 by a single p75
NCSC shortly after plating. (F–I) Downregula-
tion of SOX10 in differentiating smooth mus-
cle cells (G) and neurons (I). (J and K) Mainte-
nance of SOX10 in differentiating glia (K).
(L–S) Expression of SOX10 in NCSCs after 24
hr of exposure to: control medium (L and M);
TGF1 (N and O); BMP2 (P and Q); and GGFII/
NRG-1 (R and S).
As a preliminary step toward characterizing the mo- NRG-1 is lost in neural crest cultures from Sox10/
embryos (Paratore et al., 2001).lecular mechanism by which SOX10 maintains gliogenic
potential, we examined the expression of the transmem-
brane receptor tyrosine kinase erbB3, a receptor for SOX10 Maintains Neurogenic Potential in NCSCs
The ability of SOX10 to maintain glial potential left openGGFII/NRG-1 (Garratt et al., 2000). In vivo, Sox10 is re-
quired for maintenance of erbB3 expression in neural the question of whether it plays a broader role in main-
taining other differentiation potentials of NCSCs. To ad-crest cells (Britsch et al., 2001). RT-PCR analysis of
NCSCs in vitro revealed that preincubation for 24 hr in dress this question, we exploited the fact that pretreat-
ment of NCSCs with TGF, a smooth muscle-inducingBMP2 caused a striking (10-fold) downregulation of
erbB3 mRNA (Figure 2S, “GFP, BMP2”). By contrast, signal, causes a rapid and irreversible loss of neuronal
differentiation capacity, as revealed by subsequentin NCSCs infected with the SOX10 retrovirus, this down-
regulation was greatly attenuated (Figure 2S, “Sox10, challenge with BMP2 (Shah and Anderson, 1997). Since
TGF also rapidly downregulates SOX10 (Figure 1), weBMP2”), and erbB3 mRNA levels were restored to
50% of those in cultures lacking BMP2 (Figure 2S, asked whether constitutive expression of SOX10 could
prevent such a TGF-induced extinction of neurogenic“Sox10, BMP2”). Thus, loss of gliogenic potential
caused by preincubation in BMP2 is correlated with potential. To do this, NCSCs plated at clonal density
were infected with either the SOX10 or GFP retroviruses,downregulation of a coreceptor for GGFII/NRG-1, and
forced expression of SOX10 partially rescues this down- and incubated for 24 hr to allow expression of the retrovi-
ral transgene. Subsequently, the cells were preincu-regulation. These data suggest (although they do not
causally establish) that SOX10 may protect glial differen- bated for 24 hr in different concentrations of TGF,
washed, and then cultured in 1 nM BMP2 for a furthertiation potential from extinction by BMP2, at least in part,
by maintaining GGFII/NRG-1 responsiveness in NCSCs. 5–6 days to promote neurogenesis, and then stained for
neurofilament expression (Figure 3, schematic).Consistent with this interpretation, responsiveness to
Neuron
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Figure 2. SOX10 Preserves Glial Potential
from Extinction by BMP2
In this and other figures, the experimental de-
sign is illustrated in the flow diagram. NCSCs
were infected immediately after plating with
either GFP or SOX10-IRES-GFP retroviruses
(“Infect”). (A–P) “BMP2” or “BMP2” indi-
cates that the infected cultures were preincu-
bated for 24 hr with or without 1 nM BMP2,
followed by washout and further incubation
under glial differentiation conditions (see Ex-
perimental Procedures). Note that the 24 hr
preincubation in BMP2 extinguishes glio-
genic potential as assessed by loss of both
GFAP (B versus D) and O4 expression (J ver-
sus L), and forced expression of SOX10 res-
cues this potential (D versus H; L versus P).
Quantification (Q and R) of the percentage of
colonies containing any GFAP (Q) or O4 (R)
cells. *p 0.05 by Student’s t test. (S) SOX10
protects erbB3 from downregulation by
BMP2. Shown are RT-PCR measurements of
erbB3 and control HPRT mRNAs in NCSCs
infected with either the control GFP or the
SOX10-IRES-GFP retroviruses and then fur-
ther incubated for 24 hr with or without 1 nM
BMP2. PCR cycle number ranges from 26 to
30, in 2-fold steps.
In control GFP virus-infected cultures, preincubation differentiation was recovered following BMP2 treatment
(Figure 3D versus 3H; Figure 3I, SOX10 virus). Althoughwith increasing doses of TGF caused a progressive
loss of neuronal potential (Figure 3I, GFP virus), consis- the extent of BMP2-induced neuronal differentiation in
such cultures was lower than in controls preincubatedtent with earlier studies (Shah and Anderson, 1997). At
20 pM, TGF preincubation completely extinguished the without TGF (Figure 3I), it was greater at lower concen-
trations of TGF and was always higher than in GFP-ability of BMP2 to subsequently elicit neuronal differenti-
ation (Figure 3B versus 3D). By contrast, in SOX10 virus- infected, TGF-preincubated controls (Figure 3I, magenta
versus lavender bars). The ability of SOX10 to rescueinfected cultures preincubated in 20 pM TGF, neuronal
SOX10 Maintains Neural Crest Lineage Potentials
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Figure 3. SOX10 Preserves Neurogenic and
Gliogenic Potential from Extinction by TGF
Preincubation of GFP-infected NCSCs for 24
hr in TGF causes a dose-dependent loss of
neuronal differentiation potential, tested by
exposure to 1 nM BMP2 ([B versus D]; [I],
GFP virus; *p  0.05). Neuronal potential is
maintained in SOX10-infected cells ([D versus
H]; [I], SOX10 virus). All colonies in (A)–(H)
were virally infected, as determined by
counter staining with antibodies to GFP (data
not shown). (J–Q) SOX10 preserves glial as
well as neuronal differentiation potential from
extinction by 20 pM TGF. (J)–(L) and (N)–(P)
are individual fluorescence channels from the
triple-labeled fields shown in (M) and (Q), re-
spectively. Note that SOX10 preserves not
only neuronal (J and N) but also glial (K and
O) differentiation capacity, while reducing
smooth muscle differentiation (L and P). For
additional data and quantification see Sup-
plemental Figure S1 at http://www.neuron.
org/cgi/content/full/38/1/17/DC1.
neuronal differentiation capacity does not reflect an ef- tary Figure S1 at http://www.neuron.org/cgi/content/full/
38/1/17/DC1). Thus, constitutive expression of SOX10fect to prevent killing of neurogenic precursors by TGF,
as determined by serial observation of identified founder preserves glial, as well as neuronal, potential from ex-
tinction by TGF (Figures 3J and 3K versus 3N and 3O).cells (see below). Rather, SOX10 prevents TGF from
extinguishing neuronal differentiation potential in The observation that BMP2 can promote the develop-
ment of GFAP glia, as well as neurons, in SOX10-infectedNCSCs.
Colonies in SOX10-infected cultures exposed se- colonies may seem paradoxical, given that transient
BMP2 exposure extinguishes glial potential in controlquentially to TGF and BMP2 contained not only neu-
rons, but also many nonneuronal cells (Figures 3G and NCSCs (Figure 2). However, BMP2 promotes not only
neuronal, but also smooth muscle differentiation (see3H). To identify these cells, similar cultures were triple
labeled with antibodies to NF160, -smooth muscle ac- Supplementary Figure S1 at http://www.neuron.org/cgi/
content/full/38/1/17/DC1) (Shah et al., 1996). If BMP2-tin (SMA), and GFAP. These experiments revealed that
57% of the colonies in such cultures contained GFAP induced downregulation of endogenous SOX10 (Figure
2) is overcome by constitutive retroviral expression ofglia (Figure 3O), in addition to some smooth muscle
cells (Figure 3P; see Supplementary Figure S1 at http:// the HMG-box factor, then the nonneuronal fate pro-
moted by BMP2 is shifted from smooth muscle towardwww.neuron.org/cgi/content/full/38/1/17/DC1). In
striking contrast, in control GFP virus-infected cultures, glial (0% glial-containing colonies in controls versus
60% glial-containing colonies in SOX10-infected cul-no glia were observed (Figure 3K) and essentially all
(98%  4%) of the colonies consisted exclusively of tures; see Supplementary Figures S1A, S1C, and S1E
at http://www.neuron.org/cgi/content/full/38/1/17/smooth muscle cells (Figures 3L and 3M; see Supplemen-
Neuron
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Figure 4. SOX10 Inhibits TGF1-Induced
Cell Cycle Arrest
(A) and (B), (C) and (D), (E) and (F), and (G)
and (H) represent pairs of images from the
same fields, double labeled for DAPI to reveal
all cell nuclei (blue) and BrdU to reveal divid-
ing cells (red). Note the dose-dependent de-
crease in BrdU incorporation caused by TGF
([B versus D]; [I], GFP virus). SOX10 largely
restores BrdU incorporation even at 20 pM
TGF ([D versus H]; [I], SOX10 virus; *p 0.05).
DC1). The ability of BMP2 to promote GFAP glial differ- GFP-infected NCSCs with TGF for 24 hr caused a dose-
dependent reduction in BrdU labeling (Figures 4A–4D;entiation in SOX10-expressing NCSCs is consistent with
the ability of this growth factor to promote GFAP expres- Figure 4I, GFP virus). This effect was to a large extent
overcome by forced expression of SOX10 (Figure 4Dsion in CNS glial precursors (Nakashima et al., 1999).
Thus, if SOX10 is constitutively expressed, BMP2 can versus 4H; Figure 4I, SOX10 virus). Serial observation
of identified founder cells indicated that there was littlereveal glial as well as neuronal differentiation potentials.
In control NCSCs, both potentials are abolished by TGF or no cell death caused by the 24 hr preincubation in
TGF (see below). Despite the rescue of BrdU incorpora-preincubation (Figures 3J and 3K; Supplementary Figure
S1E at http://www.neuron.org/cgi/content/full/38/1/ tion, there were somewhat fewer cells in SOX10-infected
cultures incubated with TGF than without (Figure 4E17/DC1), and all NCSCs differentiate to a smooth muscle
fate (Figures 3J–3M, Supplementary Figures S1B and versus 4G); nevertheless, the number of cells was still
50% greater than in control TGF-treated culturesS1E at http://www.neuron.org/cgi/content/full/38/1/17/
DC1). Constitutive expression of SOX10 overrides this ef- (Figure 4C versus 4G). These data suggest that SOX10
not only preserves neuronal and glial differentiation po-fect of TGF (Figures 3N–3Q) and maintains both neu-
ronal and glial lineage potentials, as revealed by their tentials, but also proliferative activity, from extinction by
TGF. Consistent with these activities, SOX10 inhibitedresponse to BMP2.
smooth muscle differentiation induced by TGF (Sup-
plemental Figure S2 at http://www.neuron.org/cgi/SOX10 Prevents TGF-Induced Proliferative
Arrest in NCSCs content/full/38/1/17/DC1).
In the course of these experiments, we noted that colony
sizes appeared significantly larger in SOX10 virus- SOX10 Is Essential for the Induction
of Transcriptional Determinantsinfected cultures preincubated in TGF than in GFP vi-
rus-infected cultures (Figures 3C and 3G and data not of Autonomic Neurogenesis
The observation that SOX10 preserves neuronal differ-shown). As TGF strongly inhibits proliferation in NCSCs
(Shah et al., 1996), this observation suggested that entiation potential from extinction by TGF (Figure 3)
was unexpected, because genetic analysis has sug-SOX10 might inhibit such proliferative arrest. To address
this question directly, GFP or SOX10 virus-infected cul- gested that Sox10 plays a primary role in supporting
peripheral glial differentiation and survival (Britsch et al.,tures were incubated in TGF for 24 hr, washed, and
then further incubated for 24 hr before being pulsed for 2001; Paratore et al., 2001). Our observations therefore
raised the questions of the molecular mechanism under-15 hr with BrdU (Figure 4, schematic). Preincubation of
SOX10 Maintains Neural Crest Lineage Potentials
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lying this activity, as well as whether it occurs in vivo. PHOX2B, a paired homeodomain transcription factor
As a first step, we examined the relationship of SOX10 that, like MASH1, is essential for autonomic neurogen-
to the induction of MASH1, a proneural gene for the esis in vivo (Pattyn et al., 1999). Double labeling of mouse
autonomic neuronal lineage (Guillemot et al., 1993; Lo embryo sections with antibodies to SOX10 and PHOX2B
et al., 1998). Preincubation of control NCSCs in 20 pM revealed that, as in the case of MASH1, a high proportion
TGF, which extinguishes neurogenic potential (Figure (64%  19.2%) of SOX10 neural crest-derived cells
3), also strongly attenuated the induction of MASH1 by near the dorsal aorta initially coexpress PHOX2B, at E9.5
BMP2 (Figures 5A and 5C, GFP), consistent with earlier (Figures 5E and 5I, arrowheads). In Dom/Dom embryos,
studies (Shah and Anderson, 1997). The induction of however, PHOX2B expression was essentially lost in the
MASH1 was to a large extent restored by constitutive SOX10-trunc population at E9.5 (Figure 5G; 1 PHOX2B
expression of SOX10 (Figure 5B, arrowheads; Figure cell/817 SOX10-trunc cells analyzed). These data sug-
5C, SOX10). Observation of individual, identified founder gest that the initial expression of PHOX2B in neural crest
cells for 48 hr, followed by fixation and DAPI staining cells, like that of MASH1, requires SOX10 function in
to detect apoptotic nuclei, indicated that 10% of the vivo. At later stages, however, SOX10 and PHOX2B are
cells died during the course of this experiment. There- expressed in largely nonoverlapping cell populations
fore, the parallel effects of SOX10 to preserve both near the dorsal aorta (Figure 5K, arrows), as is the case
MASH1 inducibility and neurogenic potential do not re- for MASH1 cells (Figure 5J). Thus, SOX10 is required
flect a protection from TGF-mediated killing of neu- for the induction, but not the maintenance, of both
ronal precursors. MASH1 and PHOX2B in neural crest cells in vivo.
These results indicated that SOX10 attenuates the
effect of TGF preincubation to inhibit induction of Forced Expression of SOX10 Inhibits Overt
MASH1 by BMP2. This raised the question of whether Neuronal Differentiation in NCSCs
SOX10 is normally required for MASH1 expression. In The observation that SOX10 expression is ultimately
vitro, SOX10 by itself had no effect to increase Mash1 extinguished in MASH1 and PHOX2B cells (Figures
expression in the absence of BMP2 (Figure 5C), sug- 5H–5K) suggested that its continued expression might
gesting that it may play a permissive role in the expres- interfere with neuronal differentiation. To address this
sion of this proneural gene. To determine whether possibility directly, we examined neuronal differentia-
SOX10 is required for MASH1 induction in vivo, we ex- tion in clonal cultures of NCSCs constitutively express-
amined the expression of MASH1 in SOX10-expressing ing SOX10. Under standard culture conditions, the first
neural crest cells at the time they first migrate to the neurons (identified as process-bearing, NF160 cells)
dorsal aorta, a site of autonomic (sympathetic) neuro- are detected in NCSC clones after 7–7.5 days of incu-
genesis. Double labeling for MASH1 and SOX10 at E9.5 bation, and the percentage of neuron-containing colo-
revealed that a high proportion of SOX10 cells were nies increases thereafter, reaching 90% after 12
MASH1 near the dorsal aorta in wild-type embryos days (Stemple and Anderson, 1992). Similar kinetics
(Figures 5D and 5H, arrowheads; 50.3%  15.2% of were observed in cultures infected with the control GFP
SOX10 cells MASH1; n  254 SOX10 cells analyzed retrovirus (Figure 6A, GFP). By contrast, there was a
in two embryos). clear inhibition of neuronal differentiation in SOX10 vi-
To determine whether MASH1 induction in neural rus-infected cultures at all time points (Figure 6A,
crest cells is dependent on SOX10 in vivo, we examined SOX10). The extent of neuronal differentiation increased
its expression in Dom/Dom embryos, which are geno- slightly in SOX10-infected cultures at longer incubation
typically null for Sox10 (Britsch et al., 2001). To do this,
times, but this increase was correlated with a spontane-
we exploited the fact that our monoclonal antibody to
ous extinction of proviral gene expression in many cells
SOX10 recognizes an N-terminal epitope on the protein,
by this time point (Figure 6B, cf. DAPI versus GFP). Thewhich is spared by the C-terminal truncation of the
expression of neuronal markers in such SOX10-infectedSox10 coding sequence in Dom mutants (Herbarth et
clones occurred preferentially in those cells that hadal., 1998; Southard-Smith et al., 1998) (L.L. and D.J.A.,
extinguished transgene expression (Figure 6B, arrowunpublished data). This antibody therefore allowed us
versus arrowhead; 38 GFP/589 NF160 cells). By con-to directly examine the expression of MASH1 in SOX10-
trast, the majority of neurofilament-positive cells in con-trunc (truncated)-expressing neural crest cells in Dom/
trol GFP virus-infected colonies coexpressed the trans-Dom embryos. Strikingly, although in Dom/Dom em-
gene (Figure 6B, large arrow; 848 GFP/1011 NF160bryos at E9.5 there were many SOX10-trunc cells adja-
cells). Thus, SOX10 inhibits spontaneous neuronal differ-cent to the dorsal aorta (Figure 5F), the vast majority of
entiation in NCSCs. SOX10 also inhibited BMP2-inducedthese cells did not express MASH1 (1 MASH1 cell/
neuronal differentiation, albeit to a lesser extent (data516 SOX10-trunc cells, n  2 embryos). Nevertheless,
not shown).MASH1 expression was maintained in the ventral neural
tube (Figures 5D and 5F, arrows), providing an internal
Inhibition of Neurogenesis by SOX10 Is Correlatedpositive control for antibody staining. These data sug-
with Its Repression of PHOX2A, Both In Vitrogest that SOX10 is required for the initial induction of
and In VivoMASH1 in neural crest-derived autonomic precursors in
We wished to determine whether SOX10 functions tovivo. By E10.5, however, many MASH1 cells near the
inhibit overt neurogenesis in vivo as well as in vitro. Ifdorsal aorta no longer expressed SOX10 (Figure 5J,
so, then loss of SOX10 function might be expected toarrows), suggesting that the requirement of SOX10 for
cause derepression and/or precocious induction ofexpression of MASH1 is transient.
We also examined the relationship of SOX10 to some neuronal differentiation markers in autonomic pre-
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cursors. To this end, we analyzed the expression of
PHOX2A, a close relative of PHOX2B that is also ex-
pressed by developing autonomic neuroblasts (Pattyn
et al., 1997). PHOX2A is expressed 1 day later than
PHOX2B in sympathetic ganglia primordia and is never
coexpressed with SOX10 at E9.5 (Figures 7A and 7D; 0
PHOX2A cells/982 SOX10 cells analyzed in n  2
embryos). Rather, from its onset at E10.5, PHOX2A ex-
pression is mutually exclusive with that of SOX10 (Figure
7B; inset, arrows). These data suggested that SOX10
might negatively regulate PHOX2A expression (or vice-
versa). To test this, we first asked whether forced ex-
pression of SOX10 might interfere with the induction of
PHOX2A by BMP2 (Lo et al., 1998) in cultured NCSCs.
Indeed, constitutive expression of SOX10 in NCSCs
caused a 2-fold inhibition of PHOX2A induction by
BMP2, in comparison to controls (Figure 7C, SOX10
versus GFP virus). By contrast, no such inhibition of
MASH1 or PHOX2B induction by SOX10 was observed
(Figure 5C and data not shown).
To determine whether SOX10 is a negative regulator
of PHOX2A expression in vivo as well as in vitro, we
examined Dom/Dom embryos by antibody double label-
ing for SOX10-trunc and PHOX2A. In contrast to wild-
type embryos (Figure 7D), many SOX10-trunc cells
coexpressed PHOX2A at E9.5 in Dom/Dom embryos, at
axial levels anterior to the bifurcation of the dorsal aorta
(Figures 7E and 7F). (At more posterior axial levels, dere-
pression of PHOX2A was not detected; however, deple-
tion of neural crest cells has been reported to be more
severe around the caudal dorsal aorta in Dom/Dom
embryos [Britsch et al., 2001].) Near the dorsal aorta,
approximately 20% (19%  15.5%; mean  SD) of
SOX10-trunc cells were PHOX2A (Figures 7E and 7F,
arrowheads; 970 SOX10 cells analyzed in 16 sections
from 3 mutant embryos). Furthermore, many SOX10-
trunc, PHOX2A cells could be observed at ectopic
sites in the neural crest migration pathway. In wild-type
embryos, PHOX2A is normally not detected until neural
crest cells have aggregated near the dorsal aorta to
form the primordia of the sympathetic ganglia (Figure
7B). By contrast, in E9.5 Dom/Dom embryos, we ob-
served numerous instances of SOX10-trunc, PHOX2A
cells at more dorsal positions in the crest migration
pathway, adjacent to the neural tube (Figures 7E, 7F,
and 7F	, arrows; 16.4%  10.2% of SOX10-trunc cells
PHOX2A, 1117 SOX10 cells analyzed). Thus, PHOX2A
is precociously and ectopically derepressed in a subset
of SOX10 neural crest cells in Dom/Dom embryos.
Figure 5. SOX10 Is Required for the Induction of Neurogenic Tran-
scription Factors Inhibition of Neuronal Differentiation, but Not
(A and C) Preincubation in 20 pM TGF strongly attenuates subse- Maintainance of Neurogenic Potential,
quent induction of MASH1 by BMP2, in control GFP-infected NCSCs Exhibits Haploinsufficiency for Sox10
([C], lavender bars). Typically 90% of cells are MASH1 in these The inhibition of neuronal differentiation caused by con-
conditions (Shah and Anderson 1997) (data not shown). (B and C) stitutive SOX10 expression in vitro exhibited incomplete
Forced expression of SOX10 preserves MASH1-inducibility in many
penetrance (Figure 6). One possible explanation for thisinfected cells ([B], arrowheads; [C], magenta bars; *p  0.05). (D–G)
phenomenon is that the extent of such inhibition is aTransverse sections of wild-type (D and E) and Sox10/ (Dom/
Dom) embryos at E9.5, double labeled for SOX10 (green) and either sensitive function of the level of SOX10 expression (the
MASH1 ([D and F]; red) or PHOX2B ([E and G]; red). The dorsal
aortae are outlined by dashed lines. MASH1 and PHOX2B expres-
sion initially occurs in cells that coexpress SOX10 ([D and E]; arrow-
heads), and is lost in Dom/Dom mutants (F and G). Arrows indicate PHOX2B (I and K) with SOX10 in wild-type embryos. Note that at
expression of MASH1 (D and F) and PHOX2B (E and G) in ventral stages older than E9.5, many MASH1 and PHOX2B cells no longer
spinal cord. (H–K) Transient coexpression of MASH1 (H and J) and coexpress SOX10 ([J and K]; arrows).
SOX10 Maintains Neural Crest Lineage Potentials
25
tein HuD, a pan-neuronal precursor marker, was also
detected in SOX10 cells in such Sox10/ heterozy-
gotes (Figure 7K″, arrows). Triple labeling indicated that
derepression of HuD occurred in SOX10 cells in which
PHOX2A was also derepressed (Figures 7K–7K,
arrows). Although we occasionally detected rare HuD
PHOX2A cells near the dorsal aorta in wild-type em-
bryos at this stage (E9.5; Figures 7J″ and 7J, arrow-
head), such cells were SOX10 (Figure 7J	, arrowhead).
Thus, both PHOX2A and HuD are derepressed in
SOX10 crest cells in Dom/ mutants. By contrast,
PHOX2B and MASH1 appeared normally expressed in
such heterozygotes (Figure 7I and data not shown).
Thus, removal of one copy of Sox10 is sufficient to cause
precocious expression of PHOX2A and HuD in SOX10
precursors, while removal of both copies causes a fail-
ure of MASH1/PHOX2B expression and consequently
of autonomic neuronal differentiation (Figure 6). This
latter phenotype is reflected in the lack of expression
of HuD in Dom/Dom embryos (Figure 7L″).
MASH1 and PHOX2B Repress Expression
of Endogenous SOX10 in NCSCs
The opposite effects of the Dom/Dom genotype on
MASH1/PHOX2B and PHOX2A expression in neural
crest-derived autonomic precursors suggested that
SOX10 is required not only to maintain neurogenic differ-
entiation potential but also to inhibit or delay overt neu-
ronal differentiation. This raised the question of how
this inhibition is ultimately relieved to permit neuronal
differentiation to occur. One possibility is that MASH1,
PHOX2B, or PHOX2A, once having been induced, in turn
repress SOX10. To test this possibility, we examined
the expression of endogenous SOX10 protein in NCSCs
infected with retroviruses encoding these three neuro-
genic transcription factors. Both MASH1 and PHOX2B
caused a slight reduction in SOX10 expression 48 hr
Figure 6. SOX10 Inhibits Neuronal Differentiation in NCSCs after infection, in comparison to GFP virus-infected con-
trols (Figure 8M, lavender bars). By 72 hr postinfection,(A) The percentage of infected (GFP) colonies containing neurons
(NF160 cells) was quantified at the indicated time points. The re- the expression of SOX10 was severely reduced, espe-
sults represent the mean  SEM of two independent experiments. cially in MASH1-infected cells (Figure 8C versus 8F and
*p  0.05. 8L; Figure 8M, magenta bars). In contrast, PHOX2A had
(B) Neuronal differentiation in 12.5 day SOX10-infected colonies
no effect to suppress SOX10 expression (Figures 8I andoccurs preferentially in cells that have extinguished proviral gene
8M). The observation that MASH1 and PHOX2B canexpression (lower right panel, arrow); see text for quantification. By
repress (directly or indirectly) the expression of SOX10,contrast, the majority of neuronal cells in control GFP virus-infected
colonies still express the transgene (large arrow). taken together with the fact that their initial expression
is SOX10 dependent (Figure 6), suggests that a negative-
feedback loop may extinguish SOX10 expression in au-
tonomic neuronal precursors (Figure 9C).level of SOX10 expression achieved using our retroviral
expression system is only 40% higher than endoge-
nous levels; see Experimental Procedures). If so, then Discussion
removal of a single copy of endogenous Sox10 might
be expected to cause a derepression of PHOX2A in vivo. The evidence presented here suggests that SOX10 is a
multifunctional protein that contributes to several impor-There is precedent that some other functions of SOX10
in neural crest development (e.g., in melanogenesis and tant properties of NCSCs. First, SOX10 preserves both
neurogenic and gliogenic differentiation capacity fromenteric gangliogenesis) exhibit such haploinsufficiency
(Herbarth et al., 1998; Southard-Smith et al., 1998). extinction by lineage restriction factors. Second, SOX10
inhibits overt neuronal and smooth muscle differentia-We therefore asked whether any derepression of
PHOX2A in SOX10 cells could be detected in Dom/ tion. Third, SOX10 prevents TGF-induced proliferative
arrest. The extent to which these functions are indepen-embryos. Indeed, at E9.5 such precocious expression
of PHOX2A in SOX10 cells was clearly detectable near dent is discussed below. The notion that SOX10 exerts
multiple functions in the neural crest and its derivativesthe dorsal aorta (Figure 7G versus 7H; inset, arrow-
heads). Precocious expression of the RNA binding pro- is consistent with emerging evidence that SOX proteins
Neuron
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Figure 7. SOX10 Represses PHOX2A Expression Both In Vitro and In Vivo
(A and D) PHOX2A is not expressed in SOX10 cells at E9.5, and initial expression at E10.5 occurs in SOX10 cells ([B], inset, arrows). Dashed
lines demarcate dorsal aortae; arrows in (A) and (D) indicate PHOX2A expression in ventral neural tube. (C) SOX10 inhibits induction of PHOX2A
by BMP2 in vitro (magenta bars, *p  0.05). Induction of MASH1 and PHOX2B is unaffected (data not shown). (D–F) PHOX2A is precociously
derepressed in a subset of SOX10-trunc cells in E9.5 Dom/Dom mutants (E–F	); (D) section from a wild-type littermate. Arrows (E and F)
indicate ectopic expression in the neural crest migration stream (F	), arrowheads indicate premature expression near the dorsal aorta. (G–I)
Derepression of PHOX2A in SOX10 cells occurs in Sox10/ heterozygotes (Dom/; [G and H] inset, arrowheads), while expression of PHOX2B
(I) and MASH1 (data not shown) are unaffected. (J–K) Derepression of HuD is also observed in Dom/ embryos ([K″], arrows) and occurs in
SOX10 cells ([K	], arrows) that also show derepression of PHOX2A ([K and K], arrows). At this stage (E9.5) and axial level (anterior), rare
HuD PHOX2A cells are seen near the dorsal aorta in wild-type littermates ([J–J], arrowheads), but do not coexpress SOX10 ([J and J	],
arrowhead). (L–L) Expression of HuD is lost in Dom/Dom embryos (L″), while derepression of PHOX2A still occurs ([L	 and L], arrows).
are multifunctional (Akiyama et al., 2002; Wilson and SOX10 Is Required for Neurogenic as Well
as Gliogenic PotentialKoopman, 2002). While other proteins undoubtedly con-
tribute to stem cell properties, the combination of func- We have employed an experimental paradigm in which
NCSCs are preincubated with lineage commitment fac-tions exhibited by SOX10 in NCSCs seems well suited
to a role in the maintenance of the stem cell state. tors that cause a rapid loss of certain developmental
SOX10 Maintains Neural Crest Lineage Potentials
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Figure 9. Schematic Illustrating Functions and Genetic Circuitry of
SOX10 in Neural Crest Stem Cells
(A) Summary of results. Extinction of SOX10 in NCSCs (e.g., by
TGF) causes them to exit the neural crest lineage and default
to smooth muscle/myofibroblasts (SMCs) in vitro. Maintenance of
SOX10 preserves neuronal and glial lineage potentials.
(B) SOX10 inhibits overt neuronal (“N”) and smooth muscle (“SM”)
differentiation, while simultaneously maintaining multipotency ([N]
and [G]) and inhibiting proliferative arrest (circular arrow).Figure 8. Sustained Expression of MASH1 and PHOX2B Causes
(C) Interactions of SOX10 with neurogenic transcription factors. TheDownregulation of Endogenous SOX10 in NCSCs
arrows are genetic and not meant to imply direct interactions.
NCSCs were infected after plating with retroviruses encoding
MASH1, PHOX2A, or PHOX2B, and the percentage of infected
(GFP; [B, E, H, and K]) cells expressing SOX10 (C, F, I, and L) was tures incubated without TGF. Such incomplete pene-
measured 48 hr ([M], lavender bars) or 72 hr ([M], magenta bars) trance may reflect the fact that SOX proteins require
later. Note the progressive repression of SOX10 with time by MASH1
partners (Wilson and Koopman, 2002), which may be(C versus F; M), and to a lesser extent by PHOX2B (C versus L; M).
limiting in NCSCs. If so, then increasing SOX10 expres-PHOX2A has no effect (C, I, and M). *p  0.05.
sion above a certain level would have no effect; however,
removing SOX10 should have a fully penetrant phe-
notype.potentials (Shah and Anderson, 1997). This paradigm
permitted us to ask whether constitutive SOX10 expres- The observation that loss of Sox10 in vivo causes
failure of expression of the neurogenic transcription fac-sion could prevent the loss of such potentials. For exam-
ple, SOX10 prevented extinction of glial potential by tors MASH1 and PHOX2B, with essentially 100% pene-
trance, is consistent with this idea. This lack of MASH1/BMP2. Such a permissive role in glial differentiation is
consistent with earlier in vitro loss-of-function studies PHOX2B expression is unlikely to simply reflect cell
death, rather than lack of gene expression, as doubleof SOX10 (Paratore et al., 2001) and fits with its require-
ment for the differentiation of all peripheral glia in vivo labeling with the TUNEL reagent indicates that the
SOX10-trunc cells in Dom/Dom mutant embryos at(Britsch et al., 2001).
Surprisingly, we also found that constitutive expres- E9.5 are not apoptotic (data not shown). The conclu-
sion that SOX10 is required for the initial expressionsion of SOX10 prevented the rapid loss of neurogenic
(as well as gliogenic) potential caused by preincubation of MASH1 in vivo is also supported by the fact that
in Drosophila, expression of the MASH1 homologin TGF (Shah and Anderson, 1997). Although this effect
was all-or-none with respect to GFP-infected controls, ACHAETE in CNS neuroblasts is dependent on the
SOX2-related gene SoxNeuro (Buescher et al., 2002;the extent of neurogenesis in SOX10-infected cultures
exposed to TGFß was not fully restored to that in cul- Overton et al., 2002). Since SOX10 maintains neurogenic
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capacity in vitro, and is required in vivo for induction of dence of its expression on PHOX2B and/or MASH1 at
more posterior axial levels (Morin et al., 1997; Pattyn etMash1 and Phox2b, genes that are in turn required for
neurogenic capacity (Guillemot et al., 1993; Pattyn et al., 1997, 1999; Hirsch et al., 1998).
In contrast to autonomic neurons, the initial differenti-al., 1999), it follows that SOX10 is likely required for
neurogenic capacity in vivo, as well as in vitro. ation of sensory neurons appears largely unperturbed in
Sox10 mutant embryos, although glial precursor survivalOur in vivo loss-of-function data are, therefore, con-
sistent with the ability of SOX10 to preserve neurogenic and differentiation in the dorsal root ganglia (DRG) is
severely affected (Britsch et al., 2001; Sonnenberg-potential from extinction by lineage commitment factors
in vitro. Taken together with its ability to maintain glio- Riethmacher et al., 2001). This lack of an early sensory
neurogenesis defect is not inconsistent with our results,genic capacity, these data support the idea that SOX10
maintains multipotency in NCSCs. However, it is cur- since a variety of data suggest that NCSCs are restricted
to generating autonomic derivatives (Greenwood et al.,rently difficult to directly test whether SOX10 maintains
NCSC multipotency in vivo. The idea that SOX10 main- 1999; White et al., 2001; Lo et al., 2002). Thus, the oppo-
nent functions of SOX10 to maintain neurogenic poten-tains multipotency in stem cells is not inconsistent with
a later function in committed glia (Peirano et al., 2000); tial and inhibit neuronal differentiation may be limited
to progenitor cells of the autonomic sublineage.this may reflect a developmental change in its partner
proteins (Wilson and Koopman, 2002). In other systems,
SOX proteins have been shown to play multiple, sequen- The Role of SOX10 in Multipotency
tial roles within a developing lineage (Akiyama et al., and Proliferation
2002). Forced expression of SOX10 prevents TGF-induced
mitotic arrest, at the same time as it preserves neuronal
and glial potential. Is it possible that the preservationSOX10 Inhibits Autonomic Neuronal Differentiation
of such multipotency is a secondary consequence ofIn addition to maintaining the multipotency of NCSCs
the ability of SOX10 to maintain proliferation under suchin vitro, SOX10 inhibits overt neuronal differentiation.
conditions? We think this is unlikely for several reasons.It is possible that this inhibitory function is simply a
First, SOX10 preserves glial potential in BMP2 as wellsecondary consequence of the effect of SOX10 to pre-
as in TGF, but BMP2 (unlike TGF) does not induceserve multipotency. Arguing against this, however, is
proliferative arrest (Shah et al., 1996). Second, such athe fact that these two functions can be genetically
model implies that neural crest-derived cells shouldseparated in vivo, because of their different gene-dos-
cease proliferating at the time that they lose multipo-age sensitivities. PHOX2A, a marker of autonomic neu-
tency, but this is not the case. Autonomic neuronal pre-ronal differentiation, is derepressed in both Dom/ and
cursors continue to proliferate for days after the stageDom/Dom embryos, while expression of MASH1 and
when SOX10 is extinguished (DiCicco-Bloom et al.,PHOX2B is lost only in Dom/Dom homozygotes. Haplo-
1990; Verdi and Anderson, 1994). This implies that lossinsufficiency of SOX10 for the repression of neuronal
of SOX10 function in Dom/Dom embryos is unlikely todifferentiation markers has previously been reported in
cause proliferative arrest (although we have not directlyvitro (Paratore et al., 2001) as well as in the enteric
tested this). The requirement of SOX10 for MASH1 ex-nervous system in vivo (Paratore et al., 2002). Evidently,
pression in vivo, independent of any requirement fora higher level of SOX10 is required to inhibit neuronal
proliferation, would suggest that the ability of SOX10differentiation than to maintain neurogenic potential.
to maintain MASH1 inducibility in TGF is likely to beThis may explain the incomplete penetrance of the effect
independent of its effect to maintain proliferation in vitro.of SOX10 to inhibit neurogenesis in gain-of-function ex-
To the extent that MASH1 inducibility is a marker ofperiments. Although its mechanistic basis remains to be
neurogenic potential, this suggests that the mainte-determined, this genetic dissociation strongly suggests
nance of multipotency by SOX10 is not secondary tothat these two functions of SOX10 are independent.
its ability to prevent mitotic arrest. We cannot exclude,The derepression of Phox2a in Sox10 mutants may
however, that the ability of SOX10 to inhibit TGF-inducedappear paradoxical given that expression of Phox2a is
proliferative arrest is secondary to its ability to inhibitlost in the sympathetic primordia of Mash1/ or
smooth muscle differentiation.Phox2b/ mutants (Hirsch et al., 1998; Lo et al., 1998;
Pattyn et al., 1999), and that Dom/Dom mutants lack
MASH1 and PHOX2B expression. However, the ability SOX10 May Function in Multiple Progenitor
Cell Compartmentsof MASH1 to repress SOX10 in vitro (Figure 8) suggests
that in Mash1/-sympathetic ganglia there might be a In which cell type(s) does SOX10 function? In vivo,
SOX10 is initially expressed in p75, MASH1, andfailure of normal SOX10 downregulation, permitting con-
stitutive repression of PHOX2A (Figure 9C). If induction PHOX2B neural crest cells, and its expression persists
transiently in MASH1, PHOX2B cells. Therefore,of PHOX2A normally requires repression of SOX10, then
in Dom/Dom mutants lacking Sox10 function, PHOX2A SOX10 could exert its functions in either or both progeni-
tor cell compartments. The fact that SOX10 is requiredcould be derepressed despite the failure of MASH1 and
PHOX2B expression (Figure 9C). Such a mechanism for the initial induction of MASH1 and PHOX2B in vivo,
and maintains MASH1 inducibility in vitro, suggests thatdoes not, however, preclude additional enhancement of
Phox2a expression by MASH1 and/or PHOX2B (Hirsch it functions in a pre-MASH1-expressing stem cell com-
partment to maintain multipotency. On the other hand,et al., 1998; Lo et al., 1998; Flora et al., 2001). Indeed,
the fact that Phox2a is derepressed only in anterior re- the fact that SOX10 inhibits PHOX2A expression (which
normally occurs after expression of MASH1 andgions of Dom embryos may reflect a greater depen-
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gift from Genetics Institute, and recombinant human GGFII was aPHOX2B) suggests that it may also operate in MASH1,
gift from CeNeS Pharmaceuticals. In some experiments, NCSCsPHOX2B cells to inhibit or delay their differentiation
grown in GGFII for5 days were allowed to undergo further differen-into neurons. The persistence of SOX10 expression in
tiation to O4 Schwann cells, by incubation for 6 days in maturation
such cells is also likely to maintain their multipotency, medium containing 10% fetal bovine serum (FBS) and 5
M forskolin
as evidenced by the fact that constitutive expression of (Stemple and Anderson, 1992). Procedures for generating pseu-
dotyped retroviruses and additional methods can be found in Sup-SOX10 preserves gliogenic capacity in BMP2-treated
plemental Data at http://www.neuron.org/cgi/content/full/38/1/17/cells, which express MASH1 and PHOX2B. Whether the
DC1.induction of MASH1 and PHOX2B is associated with a
loss of self-renewal capacity, or whether MASH1,
Antibody StainingPHOX2B and MASH1, PHOX2B cells represent differ-
Dom/Dom embryos were generated from heterozygous intercrosses
ent types of self-renewing stem cells, remains to be and genotyped as described previously (Britsch et al., 2001). Stain-
determined. ing procedures and sources of commercial antibodies are provided
as Supplemental Data at http://www.neuron.org/cgi/content/full/38/
1/17/DC1. Results were quantified by scoring the percentage ofThe Glial Fate as a “Default” Fate for NCSCs
colonies containing 1 cell of the indicated phenotype (Shah et al.,
SOX10 inhibits neuronal and smooth muscle, but is per- 1996; Shah and Anderson, 1997; Lo et al., 2002); this represents a
missive for glial differentiation. In keeping with this, conservative parameter because we are measuring the effect of
SOX10 continues to be expressed in Schwann cells, SOX10 to prevent extinction of differentiation. All experiments were
repeated at least twice, and 100–300 clones were scored per condi-while it is extinguished in the other derivatives. Interest-
tion per experiment.ingly, there are many other regulatory genes that, like
Sox10, are expressed in NCSCs and Schwann cells but
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